Researcher
Sofie Isebaert
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory of Experimental Radiotherapy (Division)
Member
From1 Oct 2005 → 21 Feb 2016
Projects
1 - 3 of 3
- Optimization of overall treatment time for whole gland stereotactic body radiotherapy with integrated focal boosting in prostate cancerFrom6 Aug 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The Treasury of Images: exploring the opportunities for diagnosing and treating prostate cancerFrom1 Aug 2016 → 23 Nov 2020Funding: Private funding of national origin - undefined
- Hedgehog signaling in prostate cancer: clinical relevance and its potential as a target for radiosensitizationFrom1 Sep 2012 → 13 Jan 2017Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 32
- From once-weekly to semi-weekly whole prostate gland stereotactic radiotherapy with focal boosting: Primary endpoint analysis of the multicenter phase II hypo-FLAME 2.0 trial.(2023)
Authors: Lisa De Cock, Cédric Draulans, Sofie Isebaert, Karin Haustermans
Pages: 109713 - Potential Molecular Mechanisms behind the Ultra-High Dose Rate "FLASH" Effect(2022)
Authors: Ellina Macaeva, Sofie Isebaert, Karin Haustermans
- Patterns of Failure Following External Beam Radiotherapy With or Without an Additional Focal Boost in the Randomized Controlled FLAME Trial for Localized Prostate Cancer(2022)
Authors: Karin Haustermans, Cédric Draulans, Sofie Isebaert
Pages: 252 - 257 - Urethral and bladder dose-effect relations for late genitourinary toxicity following external beam radiotherapy for prostate cancer in the FLAME trial(2022)
Authors: Karin Haustermans, Sofie Isebaert, Cédric Draulans, Tom Depuydt
Pages: 127 - 132 - Using ePROMs for follow-up after palliative radiotherapy: An exploratory study with patients and health care providers(2022)
Authors: Eva Oldenburger, Sofie Isebaert, Chantal Van Audenhove, Karin Haustermans
Pages: 2355 - 2361 - Using ePROMs for follow-up after palliative radiotherapy: An exploratory study with patients and health care providers(2022)
Authors: Eva Oldenburger, Sofie Isebaert, Chantal Van Audenhove, Karin Haustermans
Pages: 2355 - 2361 - Anorectal dose-effect relations for late gastrointestinal toxicity following external beam radiotherapy for prostate cancer in the FLAME trial(2021)
Authors: Karin Haustermans, Sofie Isebaert, Cédric Draulans, Tom Depuydt
Pages: 98 - 104 - Ga-68-PSMA-11 PET, F-18-PSMA-1007 PET, and MRI for Gross Tumor Volume Delineation in Primary Prostate Cancer: Intermodality and Intertracer Variability(2021)
Authors: Cédric Draulans, Raymond Oyen, Sofie Isebaert, Frederik Maes, Steven Joniau, Robin De Roover, Gilles Defraene, Karolien Goffin, Karin Haustermans
Pages: 202 - 211 - Optimal(68)Ga-PSMA and(18)F-PSMA PET window levelling for gross tumour volume delineation in primary prostate cancer(2021)
Authors: Cédric Draulans, Robin De Roover, Sofie Isebaert, Frederik Maes, Raymond Oyen, Steven Joniau, Karolien Goffin, Karin Haustermans
Pages: 1211 - 1218 - Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: Results From the FLAME Randomized Phase III Trial(2021)
Authors: Karin Haustermans, Cédric Draulans, Sofie Isebaert
Pages: 787 - +